In our previous study, despite a significant and independent association of plasma XOR activity with serum uric acid level11, plasma XOR activity but not serum uric acid level was significantly associated with decreased flow-mediated dilatation (FMD) (preliminary findings), suggesting that XOR contributes to the pathophysiology of endothelial dysfunction through ROS production. This evidence concerns the gene XDH and endothelial dysfunction.